Name: Troglitazone
Class: Anti-Diabetes Agent (Oral Hypoglycemic)
Mechanism: glucose utilization and reduces production by receptor response to insulin.
Absorption:
Dist.:
Metabolism.:
Excretion, t½:
Toxicity/S.E.s:
Utility: May help prevent development of NIDDM.
Special Features: